New patent expiration for Allergan drug AVYCAZ
Annual Drug Patent Expirations for AVYCAZ Avycaz is a drug marketed by Allergan and is included in one NDA. It […]
Annual Drug Patent Expirations for AVYCAZ Avycaz is a drug marketed by Allergan and is included in one NDA. It […]
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is
ABILIFY (aripiprazole) Otsuka Patent: 8,518,421 Expiration: Jul 24, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of July 18, 2021 Read Post »
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER (esmolol hydrochloride) Baxter hlthcare Patent: 6,310,094 Expiration: Jul 12, 2021 See More … For
Drug Patent Expirations for the Week of July 11, 2021 Read Post »
Annual Drug Patent Expirations for BREVIBLOC Brevibloc is a drug marketed by Baxter Hlthcare and is included in one NDA.
New patent expiration for Baxter Hlthcare drug BREVIBLOC Read Post »
Annual Drug Patent Expirations for BREVIBLOC+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Brevibloc Double Strength In Plastic Container is a drug marketed by Baxter Hlthcare and
Annual Drug Patent Expirations for BREVIBLOC+IN+PLASTIC+CONTAINER Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included
New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER Read Post »
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs.
New patent expiration for Allergan drug ALPHAGAN P Read Post »
Get fresh news and insights, drug patent expirations & more…